Prostate cancer disproportionately affects Black men, who are at a significantly higher risk compared to other ethnic groups. In the UK, approximately 1 in 4 Black men will be diagnosed with prostate cancer in their lifetime, which is double the risk faced by white men. This elevated risk is compounded by the fact that Black men often develop the disease at a younger age and may experience more aggressive forms of cancer.
The impact of delayed diagnosis is profound. Black men are more likely to be diagnosed with prostate cancer at a later stage, which can limit treatment options and negatively affect outcomes. National data indicates that Black men are diagnosed with stage 3 or 4 prostate cancer at a rate of 440 per 100,000, compared to 295 per 100,000 for white men.
Early detection through proactive discussions and screening can significantly improve outcomes. Engaging in conversations about prostate health and considering PSA testing can lead to earlier diagnoses, better treatment options, and improved survival rates. It's crucial for healthcare professionals to initiate these discussions, especially with Black men over the age of 45, as they are at a higher risk and may benefit from early screening.
Ethnicity
Most common
Second most common
Third most common
Black African
Ischaemic heart diseases
Dementia and Alzheimer's disease
Prostate cancer
Black Caribbean
Black Other
White
Chronic lower respiratory diseases
1 in 4 Black men will get prostate cancer in their lifetime compare to 1 in 8 for White men and 1 in 12 for Asian men.
Black men are more likely to develop prostate cancer at a younger age.
The death rate for Black men is twice as high.
Black men are diagnosed at later stages (stages 3 and 4) more often than white men.